Category	Topic	Subtopic 	Image	Image Caption	Header 1	Info1	Header2	Info2	Header3	Info3	Header4	Info4	Header5	Info5	Header6	Info6	Header7	Info7	Header8	Info8	Header9	Info9										
Retina	General	Layers of the Retina	188_Retina.jpg	Layers of retina	How often do photoreceptor outer segments renew?	Every 10 days																										
Retina	General	Wavelengths			Rhodopsin is most sensitive to?	510nm (green)	L cone?	564-580nm	M cone?	534-545nm	S cone?	420-440nm	Excimer laser?	193nm (UV)	Argon retinal laser?	532nm (Green)	Diode laser?	810nm (IR)	Nd:YAG laser?	1064nm	Femtosecond laser?	1053nm										
Retina	General	Bruch's Membrane	"190_BruchsMembrane_1.gif, 190_BruchsMembrane_2.gif"	Periodic-acid Schiff (PAS) stained the retinal pigment epithelium and Bruch's membrane heavily*Normal Bruch's membrane	"Fusion of RPE and choriocapillaris
5 elements?
Stain with?
Choroidal neovascularization occurs within Bruch’s membrane
Outer + Inner Retinal Barriers?
"		5 elements?	"- Basal lamina of RPE
- Outer collagenous zone
- Elastin fibers
- Inner collagenous zone
- Basal lamina of choriocapillaris 
(a.k.a. ""Elastin sandwich"")"	Stain with?	PAS (+)	Outer + Inner Retinal Barriers?	"- Outer = Bruch’s membrane
- Inner = Capillary basal lamina"																				
Retina	General	Imaging	"191_Imaging_FA_1.png, 191_Imaging_FA_3.jpg, 191_Imaging_FA_4.jpg, 191_Imaging_ICG_1.jpg, 191_Imaging_OCT_1.jpg, 191_Imaging_OCT_2.jpg"	FA showing initial pigmentation in the area of the tumor (melanoma) with extensive drusen and late leak throughout the mass*FA*Small vessel vasculitis causing cystoid macular edema - late frame fluorescein angiograph*Reticular Macular Disease - Bilateral Wet Macular Degeneration and Polypoidal Choroidal Vasculopathy – ICG*Myopic Macular Degeneration - Dry OCT OS*OCT	"Fluorescein Angiography (FA)
Indocyanine Green Angiography (ICT)
Optical coherence tomography (OCT)
Size of foveola? Foveal avascular zone?
Location of fovea?
Definitions?

"		FA	"1) Fluorescein sodium
- Absorbs at 465-490nm (blue)
- Emit at 520-530nm (green)
- 80% bound to plasma protein
- 90% renal excretion
2) Phases
- Choroidal phase (10-15s)
- Arterial phase (15-18s)
- Early arteriovenous phase
- Arteriovenous phase (20-25s)
- Recirculation phase (30+s)
- Late phase (fluorescein leaves retinal circulation by 10min)
3) Hyperfluorescence
- Autofluorescence (from lipofuscin)
- Transmission defect
- Leaking (increasing blurred border)
- Pooling (accumulate in anatomic space)
- Staining (fixed margins)
4) Hypofluorescence
- Blocked fluorescence
- Filling Defect"	Indocyanine Green Angiography (ICG)	"- Absorbs at 805m; Emit at 835nm
- 98% bound to albumin (stays in choroidal vessels, so better for choroidal circulation)
- 5% iodine – avoid if shellfish allergy"	OCT	"- Time domain: higher bandwidth = higher axial res
- Frequency/Spectral domain: faster, better signal-to-noise ratio"	Size of: Foveola? Foveal asvascular zone?	"0.3mm and 0.5mm, respectively"	Location of fovea?	"4mm temporal, 0.8mm inferior to optic nerve"	Definition of macula?	>2 GCL layers	Definition of fovea?	only cones present	Definition for foveola?	ONL & GCL absent										
Retina	Macular Diseases	Central Serous Chorioretinopathy (CSCR)	"192_CSCR_1.png, 192_CSCR_2.png, 192_CSCR_3.png, 192_CSCR_4.jpg, 192_CSCR_5.jpg, 192_CSCR_6.jpg, 192_CSCR_7.jpg, 192_CSCR_8.jpg, 192_CSCR_9.jpg, 192_CSCR_10.jpg, 192_CSCR_11.jpg"	"CSR (Early phase FA)*CSR (Late phase FA, expansile dot)* CSR(Later phase FA, expansile dot)*CSR (OCT)*FA arterial*FA AV*FA AV*FA late*OCT*Opto*Redfree"	"Idiopathic serous RD w/ multifocal PEDs, RPE changes & mottled atrophy
Usually in young males
Risks?"		Risks?	"steroids, stress, type A personality"	FA & OCT?	"- FA: expansile dot (common), smokestack 
- OCT: thickened choroid (?increased hydrostatic pressure in choroid)"	Treatment? 	"- Observation (self-limited 3-4mo)
- Treat if >3-4mo, recurrent, permanent changes
- Laser speeds recovery, not VA outcome
- PDT (half-fluence), rifampin, spironolactone"	Ddx of serous RD?	"- CNV (+leakage)
- PCV (saccular outpouchings)
- ON pit (no leakage)
- VKH / SO 
- posterior scleritis
- lymphoma
- pre-eclampsia / severe HTN 
- choroidal tumor
- toxoplasmosis / syphilis"																		
Retina	Macular Diseases	Age-Related Macular Degeneration (AMD)	"193_DryAMD_1.png, 193_DryAMD_2.jpg, 193_DryAMD_3.jpg, 193_DryAMD_5.jpg"	AMD Dry Hydrophilic Drusen and Geographic Atrophy*Hyperpigmentation of the Retinal Pigment Epithelium in Dry AMD*Basal Laminar Drusen*Reticular Pseudodrusen	"Dry AMD
- Associated with?
- Drusen: Quality? Deposits? Size?
- Geographic Atrophy: AF? Ddz of GA?
Cuticular (Basal Laminar) Drusen?
Reticular Pseudodrusen?

"		Dry AMD: Associated with?	"age, smoking, positive family history, female, light iris, hyperopia, HTN, hypercholesterolemia"	Drusen: Hard vs. Soft?	"- Hard: nodular thickening of BM of RPE
- Soft: focal PED (separation from Bruch’s)"	Drusen: Basal Laminar vs. Linear deposits?	"- Electron microscopy characterization
- BLamD: between plasma & BM of RPE
- BLinD: external to BM of RPE"	Drusen: Size?	"- Small <64um
- Intermediate 64-124um
- Large >124um"	Geographic Atrophy: AF?	- Decreased AF w/ ring of increased AF predict areas of GA expansion	Geographic Atrophy: Ddx of GA?	Cuticular (Basal Laminar) Drusen?	"- Type of early hard drusen (age 30-40s) 
- Many small, uniform, demarcated drusen, better seen on FA with “stars-in-the-sky” appearance
- May develop large vitelliform detachment"	Reticular Pseudodrusen?	"- Interlacing network of 125-250um drusen
-  First appear in superotemporal macula
-  Better seen on red-free, NOT on FA /ICG
-  “Sawtooth” subretinal deposits on OCT"											
Retina	Macular Diseases	Dry AMD			"Dry AMD
- Treatment: AREDS, AREDS 2, Others
- Epidemiology: Framingham Eye Study
- Experimental Models"		AREDS	"- Components? Vitamins C & E, beta carotene, copper, zinc
- 25% reduction in progression to advanced AMD
- 19% reduction in VA loss over 5 yrs
- Criteria? 
Bilateral intermediate (many int or 1 large)
Unilateral advanced AMD (wet AMD or GA)
- Avoid in smokers? Beta carotene"	AREDS 2	"- Components?
 Antioxidants w/o beta carotene, omega-3 fatty acid, xanthophylls (zeaxanthine, lutein)"	Other Treatments	"- Immunomodulation: Copaxone (subQ NSAID)
- Neuroprotection: Brimonidine (inc BDNF, dec glial activation); CNTF (e.g. secreting liposomes)"	Epidemiology: Framingham Eye Study	"6% in age >65
20% in age>75"	Experimental Models	"Poly (I:C)
RIP3 -/-
RIP1 -/-
CX3CR1 1/1
CCL2  -/-
RD10"																
Retina	Macular Diseases	Choroidal Neovascularization (CNV)	"195_CNV_1.jpg, 195_CNV_3.jpg, 195_CNV_4.jpg"	OCT of occult CNV*FA of classic CNV*FA of classic CNV	"Choroidal Neovascularization (CNV)
- Classificaton?
- Classic Definition?"		Classification?	"Type 1
- Under RPE
Type 2
- Between RPE + photoreceptors
Type 3
- Retinal angiomatous proliferations (RAP)"	Classic Definitions?	"Classic CNV
- Early hyper + late leakage
Occult CNV
- Stippled/granular early hyper + late stain
- 2 types: fibrovascular PED vs. late leakage of undetermined source
Types
- Predominantly Classic (>49% classic)
- Minimally Classic (<49% classic)
- Occult w/o Classic (no classic)"																						
Retina	Macular Diseases	Choroidal Neovascularization (CNV)	195_CNV_2.jpg	Retinal Angiomatous Proliferation - Type III choroidal neovascular membrane	"Retinal Angiomatous Proliferation (RAP)
- Yannuzzi Classification?"	"Stage 1
- Intraretinal NV / leakage
Stage 2
- Subretinal NV + serous PED
Stage 3
- Choroidal NV + fibrovascular PED
- FA: retinochoroidal anastamoses"																										
Retina	Macular Diseases	Wet AMD Treatments			"Laser: MPS
PDT: TAP, VIP
Anti-VEGF
- Pegaptanib
- Ranibizumab
- Bevacizumab
- Afilbercept"		MPS	"- Extrafoveal & Juxtafoveal: Laser all (AMD, POHS, idiopathic)
- Subfoveal: (only AMD studied)
<2DD, laser
2-3.5DD, treat if <20/200
>3.5DD, don’t laser
- Laser only classic, not occult
- Argon = krypton (no difference)"	PDT  	"Regular vs. Reduced fluence?
- Regular: 600mW/cm2
- Reduced: 300mW/cm2"	TAP	PDT > control in classic CNV	VIP	"- PDT > control in occult CNV (w/o classic)
- Small area (<4DA) and low vision (<20/30)
- PDT studies also evaluated myopia"	Pegaptanib (Macugen)	"- pegylated anti-VEGF RNA aptamer 
- binds VEGF 165
- 0.3mg"	Ranibizumab (Lucentis)	"- 48kD Fab of Mab (<50kD to cross retina)
- targets VEGF-A
- 0.3mg (DME), 0.5mg (AMD), 2mg"	Bevacizumab (Avastin)	"- full-length Mab + Fc
- targets VEGF-A
- 1.25mg, 2.5mg"	Aflibercept (Eylea)	"- ligand-binding domain of VEGFR _ + IgG Fc
- binds VEGF-A & placental-like GF
- 2mg, 4mg"										
Retina	Macular Diseases	Wet AMD Treatments: Studies			VISION	"- Macugen q6wks x 48wks > sham
- Improved VA in all CNV"	MARINA	"- Lucentis q4wks x 2yrs > sham
- Minimally-classic or occult w/o classic CNV"	ANCHOR	"- Lucentis q4wks x 2yrs > PDT q3mo PRN
- Predominantly-classic CNV"	PIER	"- Lucentis q4wks x 3 then q12wks
- Steady decline after 3mo c/w q4wks"	PrONTO	"- Lucentis q4wks x 3 then PRN (VA loss + fluid, CRT inc, mac hem, new cl CNV, persistent fluid s/p inj)
- Comparable to q4wks; 5.6inj/yr, but q4wk visits
"	SUSTAIN	"- Lucentis q4wks x 3 then PRN (VA loss, CRT inc)
- Comparable to q4wks; 5.3inj/yr, but q4wk visits
"	HORIZON	"- MARINA/ANCHOR/FOCUS pts  tx w/ PRN Lucentis q4wks s/p 2yrs
- Continued less frequent dosing -> VA loss"	CATT	"- Lucentis = Avastin q4wks or PRN in VA (<5letter diff)
- Lucentis > Avastin q4wks or PRN in OCT fluid (~10%)
- Avastin > Lucentis in adverse events (24 vs 19%)"	FOCUS	"- Lucentis + PDT > PDT alone
- Predominantly-classic CNV"	"SUMMIT (MONT BLANC, DENALI, EVEREST)"	"- Lucentis + PDT = Lucentis alone
- Except IPCV (Lucentis + PDT > Lucentis)"	CABERNET	- Lucentis + epimacular brachy vs Lucentis	RADICAL	"- Lucentis + PDT + Dexamethasone vs Lucentis
"	VIEW1 & 2	- Eylea q1mo x 3 -> q2mo = Lucentis q1mo	HARBOR	- Lucentis 0.5mg q4wks vs PRN vs 2mg q4wks vs PRN